Related Experiment Video
Updated: May 30, 2026
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
Published on: March 4, 2017
In vivo pharmacokinetics, long-term biodistribution and toxicology study of functionalized upconversion nanoparticles
Liang Cheng1, Kai Yang, Mingwang Shao
1Institute of Functional Nano & Soft Materials Laboratory (FUNSOM), Soochow University, Suzhou, Jiangsu 215123, China.
Aims:
We investigated the in vivo pharmacokinetics, long-term biodistribution and toxicology of polymer-coated upconversion nanoparticles (UCNPs) in mice.
Materials & Methods:
Near infrared emitting Yb(3+)/Tm(3+)-doped NaYF(4) UCNPs coated with either polyethylene glycol (PEG) or polyacrylic acid (PAA) were intravenously injected into mice. Blood levels of UCNPs were measured. Yttrium levels in various organs were measured to determine the biodistribution of UCNPs over 3 months. Serum biochemistry, hematology and histology assays were conducted for in vivo toxicology assays.
Results:
UCNP-PEG exhibited improved stability in physiological solutions and prolonged blood circulation half-lives more than UCNP-PAA. No noticeable toxic side effect was noticed for either UCNP-PAA or UCNP-PEG in our toxicology study, despite the long-term retention of those nanoparticles in the reticuloendothelial systems including the liver and spleen of mice.
Conclusion:
Although more systematic investigations are still required, the absence of appreciable toxicity shown in our study encourages future explorations of UCNPs for in vivo biomedical applications.
